Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial

IMPORTANCE: Although bevacizumab is a standard of care in combination treatments for metastatic colorectal cancer (mCRC), its clinical benefit has been limited. OBJECTIVE: To determine whether sequential scheduling of bevacizumab administration in combination with chemotherapy improves treatment eff...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Netw Open
Autors principals: Avallone, Antonio, Piccirillo, Maria C., Nasti, Guglielmo, Rosati, Gerardo, Carlomagno, Chiara, Di Gennaro, Elena, Romano, Carmela, Tatangelo, Fabiana, Granata, Vincenza, Cassata, Antonino, Silvestro, Lucrezia, De Stefano, Alfonso, Aloj, Luigi, Vicario, Valeria, Nappi, Anna, Leone, Alessandra, Bilancia, Domenico, Arenare, Laura, Petrillo, Antonella, Lastoria, Secondo, Gallo, Ciro, Botti, Gerardo, Delrio, Paolo, Izzo, Francesco, Perrone, Franco, Budillon, Alfredo
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2021
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314140/
https://ncbi.nlm.nih.gov/pubmed/34309665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2021.18475
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars